EUVIMEDEUVIMED entdecken
Open Access

Arginine demethylation of Serine/Arginine‐rich splicing factor 1 enhances miRNA enrichment in small extracellular vesicles derived from pancreatic ductal adenocarcinoma cells

Kritisha Bhandari iD, Jeng Shi Kong iD, Wang-Ting Tina Ho iD, Philip C Bourne iD, Blaine H M Mooers iD, Wei-Qun Ding iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202401811rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Kritisha Bhandari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: Serine-Arginine Splicing Factors, MicroRNAs, Extracellular Vesicles, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: DOD | USA | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP), Presbyterian Health Foundation (PHF), NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small extracellular vesicles (sEVs) are enriched in certain miRNAs, impacting the progression of pancreatic ductal adenocarcinoma (PDAC). The mechanisms involved in the selective sEV miRNA enrichment remain to be elucidated. We recently reported that Serine/Arginine‐rich splicing factor 1 (SRSF1) regulates selective sEV miRNA enrichment in PDAC cells. SRSF1 is an onco‐protein that is overexpressed in PDAC, and its function is dictated by posttranslational modifications such as phosphorylation and arginine methylation. The objective of this study was to examine the role of phosphorylation and arginine methylation in SRSF1‐mediated sEV miRNA enrichment in PDAC cells. Treatment of PDAC cells with the protein arginine methyltransferase inhibitors AMI‐5 and EPZ015666, but not with the phosphorylation inhibitor SRPIN340, selectively enhanced the level of sEV miR‐1246, a miRNA known to be highly enriched in PDAC sEVs. Consistently, overexpression of the mutant SRSF1 with the three arginine residues R93, R97, and R109 being replaced with lysinaugmented sEV miR‐1246 levels in both wild‐type and SRSF1‐knockdown PANC‐1 cells. Interestingly, the binding of SRSF1 to miR‐1246 was significantly reduced in PDAC cells overexpressing the mutant SRSF1, which was further confirmed using purified wild‐type and the mutant SRSF1 proteins. We demonstrate that arginine demethylation of SRSF1 reduces SRSF1‐miRNA binding in PDAC cells and enhances selective sEV miRNA enrichment, providing novel insight into SRSF1‐mediated sEV miRNA enrichment in PDAC cells and opening up new avenues of investigation on the biology and function of extracellular vesicles in PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serine-Arginine Splicing FactorsMicroRNAsExtracellular VesiclesCarcinoma, Pancreatic DuctalArgininePancreatic NeoplasmsHumansCell Line, TumorMethylationProtein-Arginine N-MethyltransferasesGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

SRSF1miRNAmiR‐1246pancreatic ductal adenocarcinoma (PDAC)protein arginine methylationsmall extracellular vesicles (sEVs)

Substanzen

Serine-Arginine Splicing FactorsMicroRNAsArginineSRSF1 protein, humanProtein-Arginine N-Methyltransferases

Autor:innen und Institutionen

  • Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Department of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma, USA.
  • Department of Physiology and Biochemistry, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

ORCID-Profile: Kritisha Bhandari, Jeng Shi Kong, Wang-Ting Tina Ho, Philip C Bourne, Blaine H M Mooers, Wei-Qun Ding

Förderung

  • DOD | USA | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP)
  • Presbyterian Health Foundation (PHF)
  • NIGMS NIH HHS
  • HHS | NIH | National Cancer Institute (NCI)
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • NCI NIH HHS
  • Congressionally Directed Medical Research Programs
  • National Institute of General Medical Sciences

Zitieren

APA

Bhandari, K., Kong, J. S., Ho, W. T., Bourne, P. C., Mooers, B. H. M., & Ding, W. Q. (2025). Arginine demethylation of Serine/Arginine‐rich splicing factor 1 enhances miRNA enrichment in small extracellular vesicles derived from pancreatic ductal adenocarcinoma cells. The FASEB Journal. https://doi.org/10.1096/fj.202401811rr

Vancouver

Bhandari K, Kong JS, Ho WT, Bourne PC, Mooers BHM, Ding WQ. Arginine demethylation of Serine/Arginine‐rich splicing factor 1 enhances miRNA enrichment in small extracellular vesicles derived from pancreatic ductal adenocarcinoma cells. The FASEB Journal. 2025. doi:10.1096/fj.202401811rr

BibTeX
@article{Bhandari2025,
  author = {Bhandari, Kritisha and Kong, Jeng Shi and Ho, Wang-Ting Tina and Bourne, Philip C and Mooers, Blaine H M and Ding, Wei-Qun},
  title = {Arginine demethylation of Serine/Arginine‐rich splicing factor 1 enhances miRNA enrichment in small extracellular vesicles derived from pancreatic ductal adenocarcinoma cells},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202401811rr}
}
Kostenlos starten →